Document is current
Any future updates will be listed below
-
Authors
Pavlou, Marina https://orcid.org/0000-0002-8290-0656
Probst, Marlene https://orcid.org/0009-0006-4476-6851
Kaplan, Lew
Filippova, Elizaveta
Prieve, Aric R
Rieke, Fred
Reh, Thomas A https://orcid.org/0000-0002-3524-0886
-
Funding
Funding for this research was provided by:
HHS | NIH | National Eye Institute (NEI R01EY021482)
UCSF | Weill Institute for Neurosciences, University of California, San Francisco (Weill Neurohub Fellowship)
Gilbert Family Foundation (Vision Restoration Initiative LLC)
Tenpoint Therapeutics Ltd (no specific number)
- License Information
-
More Information
Article History
Received: 13 September 2024
Revised: 20 February 2025
Accepted: 21 February 2025
First Online: 6 March 2025
Disclosure and competing interests statement
: Some of the findings in this report are part of a patent application that has been submitted by the University of Washington: Patent Application 63/362,361 filed 4 January 2022. TAR is a co-founder of Tenpoint Therapeutics Ltd. The remaining authors declare no competing interests.
